Hansjörg Eibl

6.6k total citations · 2 hit papers
101 papers, 5.7k citations indexed

About

Hansjörg Eibl is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Hansjörg Eibl has authored 101 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 31 papers in Organic Chemistry and 16 papers in Biochemistry. Recurrent topics in Hansjörg Eibl's work include Lipid Membrane Structure and Behavior (37 papers), Organophosphorus compounds synthesis (15 papers) and Lipid metabolism and biosynthesis (15 papers). Hansjörg Eibl is often cited by papers focused on Lipid Membrane Structure and Behavior (37 papers), Organophosphorus compounds synthesis (15 papers) and Lipid metabolism and biosynthesis (15 papers). Hansjörg Eibl collaborates with scholars based in Germany, United States and Austria. Hansjörg Eibl's co-authors include William E.M. Lands, H. Träuble, Paul Woolley, V. Neuhoff, Alfred Blume, Clemens Unger, Max Teubner, Klaus Weber, David Henderson and J. Stümpel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and The Journal of Physical Chemistry B.

In The Last Decade

Hansjörg Eibl

101 papers receiving 5.3k citations

Hit Papers

Clear background and highly sensitive protein staining wi... 1969 2026 1988 2007 1985 1969 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hansjörg Eibl Germany 40 4.1k 953 550 528 449 101 5.7k
David G. Gorenstein United States 49 5.6k 1.4× 1.4k 1.5× 1.1k 1.9× 468 0.9× 559 1.2× 257 8.5k
Philip L. Yèagle United States 44 5.8k 1.4× 681 0.7× 609 1.1× 457 0.9× 292 0.7× 141 7.3k
Barry R. Lentz United States 45 5.8k 1.4× 913 1.0× 619 1.1× 343 0.6× 474 1.1× 143 7.9k
D. Papahadjopoulos United States 37 6.3k 1.6× 740 0.8× 547 1.0× 317 0.6× 744 1.7× 48 8.1k
J. de Gier Netherlands 48 6.0k 1.5× 841 0.9× 743 1.4× 807 1.5× 355 0.8× 135 8.0k
Adrian Goldman Finland 44 7.0k 1.7× 972 1.0× 539 1.0× 448 0.8× 329 0.7× 178 10.8k
Maurice R. Eftink United States 33 5.3k 1.3× 1.1k 1.2× 1.0k 1.9× 189 0.4× 316 0.7× 99 7.5k
Jacqueline A. Reynolds United States 37 5.4k 1.3× 902 0.9× 1.2k 2.2× 299 0.6× 477 1.1× 60 7.6k
Rodney L. Biltonen United States 44 6.1k 1.5× 953 1.0× 665 1.2× 299 0.6× 293 0.7× 122 7.1k
Gerald R. Grimsley United States 24 5.5k 1.4× 511 0.5× 550 1.0× 165 0.3× 391 0.9× 31 7.3k

Countries citing papers authored by Hansjörg Eibl

Since Specialization
Citations

This map shows the geographic impact of Hansjörg Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansjörg Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansjörg Eibl more than expected).

Fields of papers citing papers by Hansjörg Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hansjörg Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansjörg Eibl. The network helps show where Hansjörg Eibl may publish in the future.

Co-authorship network of co-authors of Hansjörg Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of Hansjörg Eibl. A scholar is included among the top collaborators of Hansjörg Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hansjörg Eibl. Hansjörg Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaharieva, Maya M., et al.. (2012). Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins. Journal of Cancer Research and Clinical Oncology. 138(11). 1909–1917. 30 indexed citations
2.
Henke, Guido, Lars H. Lindner, Hansjörg Eibl, et al.. (2012). Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice. Radiation Oncology. 7(1). 172–172. 10 indexed citations
3.
Hossann, Martin, et al.. (2012). Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. Journal of Controlled Release. 162(2). 400–406. 69 indexed citations
4.
5.
Hossann, Martin, Tungte Wang, Michael Wiggenhorn, et al.. (2010). Size of thermosensitive liposomes influences content release. Journal of Controlled Release. 147(3). 436–443. 92 indexed citations
6.
Henke, Guido, Lars H. Lindner, Michael Vogeser, et al.. (2009). Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy. Radiation Oncology. 4(1). 46–46. 13 indexed citations
7.
Hossann, Martin, Michael Wiggenhorn, Kirsten Wachholz, et al.. (2007). In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(10). 2491–2499. 110 indexed citations
8.
Kratzmeier, Martin, et al.. (2007). Apoptotic DNA fragmentation is not related to the phosphorylation state of histone H1. Biological Chemistry. 388(2). 197–206. 9 indexed citations
10.
Jendrossek, Verena, Ilka Müller, Hansjörg Eibl, & Claus Belka. (2003). Intracellular mediators of erucylphosphocholine-induced apoptosis. Oncogene. 22(17). 2621–2631. 52 indexed citations
11.
Kugler, Wilfried, et al.. (2002). Erucylphosphocholine‐induced apoptosis in glioma cells: involvement of death receptor signalling and caspase activation. Journal of Neurochemistry. 82(5). 1160–1170. 14 indexed citations
12.
Seifert, Karin, Michael Duchêne, Walther H. Wernsdorfer, et al.. (2000). A New Approach for Chemotherapy Against Entamoeba histolytica. Archives of Medical Research. 31(4). S6–S7. 3 indexed citations
13.
Konstantinov, Spiro, Hansjörg Eibl, & Martin Berger. (1999). BCR‐ABL influences the antileukaemic efficacy of alkylphosphocholines. British Journal of Haematology. 107(2). 365–374. 144 indexed citations
14.
Sobottka, Stephan B., Martin R. Berger, & Hansjörg Eibl. (1993). Structure‐activity relationships of four anti‐cancer alkylphosphocholine derivatives In Vitro and In Vivo. International Journal of Cancer. 53(3). 418–425. 21 indexed citations
15.
Berkovic, Dinko, et al.. (1990). Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells. Journal of Cancer Research and Clinical Oncology. 116(5). 459–466. 41 indexed citations
16.
Dannenberg, Andrew J., Timothy C. Wong, David Zakim, & Hansjörg Eibl. (1990). Synthesis and use of a lysolecithin analog for the purification of UDP-glucuronosyltransferase. Analytical Biochemistry. 191(1). 183–186. 5 indexed citations
17.
Berger, Martin R., Heike Richter, Matthias H. Seelig, Hansjörg Eibl, & D. Schmähl. (1990). New cytostatics—more activity and less toxicity. Cancer Treatment Reviews. 17(2-3). 143–154. 15 indexed citations
18.
Hilgard, Peter, Jurij Stekar, R. Voegeli, et al.. (1988). Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). European Journal of Cancer and Clinical Oncology. 24(9). 1457–1461. 92 indexed citations
19.
Eibl, Hansjörg, et al.. (1981). [53] Preparation of phospholipids and their analogs by phospholipase D. Methods in enzymology on CD-ROM/Methods in enzymology. 72. 632–639. 121 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026